Is Viking Therapeutics a Millionaire-Maker Stock?

Among the hottest investments these days are pharma and biotech companies that make weight loss drugs. Demand for these products surpasses supply, and analysts predict that sales growth for the new classes of effective treatments is just getting started. According to a forecast by Goldman Sachs Research, the global weight loss drug market may multiply by a factor of 16 to reach $100 billion by the end of the decade. Unlike Eli Lilly and Novo Nordisk, Viking is a clinical-stage company. It doesn't have any p ...